Vascular occlusion in the infraorbital and cheekbone area

The infraorbital and cheekbone area is one of the most requested in the clinic: under-eye hollows, midface projection, correction of folds. It is also one of the areas that demand the most vascular respect. Between the lower eyelid, the nasal ala and the apple of the cheek run branches of the infraorbital artery, the angular artery and the transverse facial artery, in a network whose connection with the ocular circulation explains why an occlusion here can be more than a skin problem.

This page is a review of anatomy, signs and how to organize the initial management. It does not teach injection technique, includes no doses or dilutions, and does not replace training or current guidelines. The general concept is in vascular occlusion, and the big picture is in vascular danger zones of the face.

What makes this area special?

Three features combine.

• An arterial network with many connections. The infraorbital branch emerges from the foramen below the orbit and supplies the lower eyelid, the cheek and the upper lip, anastomosing with the angular artery and with branches of the facial artery. The angular artery, in turn, climbs along the side of the nose and connects with the territory of the ophthalmic artery. See vascular anastomoses of the face.
• Thin, unforgiving tissue. The skin of the lower eyelid and the tear trough is thin, and swelling or accumulated product shows easily. That makes visual diagnosis easier, but it also leaves a smaller aesthetic margin for error.
• Proximity to the eye. Vascular changes near the orbit have the rare potential to affect ocular structures, which changes the severity and the type of referral.

Supporting anatomy is in periorbital anatomy for injectables. To assess the under-eye concern itself, see under-eye hollows: types and assessment.

In which procedures does this risk appear?

The risk does not belong to a single procedure: it comes with any injection into vascularized tissue. In practice, attention focuses on:

• Tear trough filler and lower eyelid smoothing.
• Cheekbone filler, especially in the anteromedial area, close to the infraorbital branch and the nasolabial fold.
• Biostimulator treatments in the cheeks and under-eye area, where enzymatic reversal is not possible. See biostimulator in the under-eye area.
• Threads and other approaches that cross the territory, discussed in PDO threads in the periorbital area.

What are the signs of occlusion in the infraorbital area?

The signs follow the general logic, with site-specific particularities. The table organizes them by phase.

How do you tell it from swelling, bruising and other conditions?

The infraorbital area swells and bruises very easily, and it is common to wonder what is expected.

Comparing both sides under good light, with the patient seated and facing you, helps more than looking at one isolated area. Clinic lighting also affects this reading, as in lighting in the HOF clinic.

Initial management when occlusion is suspected

At review level, complication protocols organize the first response like this:

1. Stop the injection and place no more product in the area.
2. Assess color, capillary refill, temperature and extent, and ask about vision and eye pain.
3. If there is any visual symptom, activate the ophthalmic emergency immediately, without waiting for the skin to evolve.
4. With hyaluronic acid, use hyaluronidase according to current guidelines and the professional's judgment, reassessing perfusion often.
5. Adjuvant measures and systemic medications appear in protocols with variable evidence, and prescribing them is a medical decision.
6. Record times, findings, serial photos and actions taken.
7. Do not discharge the patient without signs of reperfusion and without a follow-up and contact plan.
8. Refer if there is worsening, an extensive area or doubt.

How to organize stock and staff is covered in hyaluronidase in the clinic and in emergency kit for the HOF clinic.

How can the risk be reduced?

No measure eliminates the risk. At review level, the most cited strategies are:

• Know the anatomy and individual variation, and do not rely on a fixed "safe" zone.
• Prefer conservative volumes per session, with a touch-up when needed, especially in a thin or previously treated lower eyelid. See malar bags: assessment to understand when filling is not the answer.
• Choose instrument and product carefully, as discussed in cannula or needle.
• Watch the skin color throughout the procedure, not only at the end.
• Respect the limits of the indication: not every under-eye hollow is a volume problem. Pigmentation and vessels call for a different path, as in infraorbital hyperpigmentation after a procedure.
• Consider alternatives when the tissue is very thin, such as skin booster in the under-eye area.

After the acute phase

Even with reperfusion, the area needs short follow-ups, photos in the same standard and easy contact. Scabs, flaking and color changes can last for weeks. When there is necrosis, wound care and medical evaluation come in, and planning starts to include the scar and the contour. Any eye complaint, at any stage of follow-up, is an emergency again. The case note in the patient record should include times, findings and instructions given, as in patient record and documentation in HOF.

How to talk to the patient

Give the instructions in writing and confirm that the patient knows the contact number. If a question comes up outside office hours, the channel has to really exist.

And in Harmy?

For context on the areas, see the area pages under-eye hollows and cheekbone.

Summary

The infraorbital and cheekbone area combines high demand, thin skin and vascular anatomy that connects with the eye. The key points are that a visual symptom is an emergency, that skin color can mislead in higher phototypes, that hyaluronidase acts only on hyaluronic acid and that the best time to prepare is before you start. Review the clinic protocol periodically and train the team so the response to the first sign is fast and organized.